Back to AVXL
Cambridge Investment Research Advisors, Inc. → AVXL
Cambridge Investment Research Advisors, Inc. AVXL Position History
Anavex Life Sciences Corp. • Healthcare
Quarters held
6
Latest value
$24K
Q3 2026
Peak value
$188K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $188K |
| Q4 2025 | $79K |
| Q1 2026 | $46K |
| Q2 2026 | $36K |
| Q2 2026 | $36K |
| Q3 2026 | $24K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $24K | 12.1K | — | — |
| Q2 2026 | $36K | 14.0K | — | — |
| Q2 2026 | $36K | 14.0K | — | — |
| Q1 2026 | $46K | 15.0K | — | — |
| Q4 2025 | $79K | 22.1K | — | — |
| Q3 2025 | $188K | 21.1K | — | — |
Other funds holding AVXL
$45.3M
$40.8M
$39.5M
$37.2M
$34.2M
$33.9M
$29.3M